THE CULTURE WAR
HEALTH
FDA Approves Sanofi's Infilbray, First Drug to Cross Into Brain for Rare Type 3 Gaucher Disease
International Business Times UK
— November 19, 2026 at 06:33 AM UTC
■ Source Bias Analysis
1 rating found
LEFT
LEAN LEFT
CENTER
LEAN RIGHT
RIGHT
Wikipedia
GENERALLY UNRELIABLE
International Business Times
The FDA has approved Sanofi's oral drug Infilbray for adults and children weighing at least 15 kilograms with type 3 Gaucher disease neurological symptoms.
READ MORE AT SOURCE »
Originally reported by
International Business Times UK
HOW DO YOU SEE THIS STORY?
Choose your pill. Your vote is anonymous.
RED PILLED
0
BLUE PILLED
0
BLACK PILLED
0
0 TOTAL VOTES
SCAN TO SHARE
« Back to The Culture War